ADI-PEG 20 Seen to Improve Response to Chemo in MPM Patients in Extension Trial
News
Results from a Phase 1 extension study further confirmed the potential of ADI-PEG 20 to enhance the effectiveness of two chemotherapies — Platinol (cisplatin) and Alimta (pemetrexed) — commonly used to treat ... Read more